ARCHIVES

Tivozanib Trumps Sorafenib In 1st-Line Renal Cancer Study

This article is from The Cancer Letter archive.

Vol. 35 No. 5 | May 25, 2012

Download PDF Visit The Full Archive

Related Articles

Cranial Radiation Eliminated With Personalized Chemo

August 28, 2009

NCI Considering Adoption Of NIGMS Guidelines To Limit Growth Of Renewals, Ensure New Grants

November 30, 1990

Study tests a “truth” in radiation oncology, raises questions about anemia treatment.

October 24, 2003

Obituary: Ruth Kirschstein, 82, NIH Administrator, Scientist, Mentor. House Member Softens Breast Cancer Bill

October 9, 2009

New Colorado Center Gets Core Grant

February 5, 1988

Continuing Resolution Expires March 27; NIH, NCI Hope For Budget Compromise

March 15, 2013